Extraordinary by its absence during July is any common theme to the price movements seen during the month: the only product to show any kind of trend was sertraline tabs which had two packs among the month’s purchase price ‘fallers’. It is too early to say whether this is a result of the Summer ‘silly season’ or an early sign that shortages are abating.
What is clear, however, is that July was a good month for dispensing doctors, who were able to negotiate the best deals for both generics and PIs, compared to pharmacies. Only time will tell if doctors can maintain their superior PI buying power as they continue to do with generics.
DDA members can view the full purchase price analysis by visiting the library of monthly purchase price analyses.